Logo image of CAN

CANAAN INC (CAN) Stock Fundamental Analysis

NASDAQ:CAN - Nasdaq - US1347481020 - ADR - Currency: USD

0.6875  0 (-0.68%)

After market: 0.6924 +0 (+0.71%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CAN. CAN was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. CAN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CAN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CAN has reported negative net income.
In the past year CAN has reported a negative cash flow from operations.
In multiple years CAN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CAN reported negative operating cash flow in multiple years.
CAN Yearly Net Income VS EBIT VS OCF VS FCFCAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

CAN has a worse Return On Assets (-83.97%) than 84.38% of its industry peers.
The Return On Equity of CAN (-118.96%) is worse than 62.50% of its industry peers.
Industry RankSector Rank
ROA -83.97%
ROE -118.96%
ROIC N/A
ROA(3y)-12.81%
ROA(5y)-32.65%
ROE(3y)-16.7%
ROE(5y)-49.54%
ROIC(3y)N/A
ROIC(5y)N/A
CAN Yearly ROA, ROE, ROICCAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

1.3 Margins

CAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAN Yearly Profit, Operating, Gross MarginsCAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CAN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CAN Yearly Shares OutstandingCAN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
CAN Yearly Total Debt VS Total AssetsCAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -1.10, we must say that CAN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.10, CAN is doing worse than 71.88% of the companies in the same industry.
CAN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.1
ROIC/WACCN/A
WACC8.89%
CAN Yearly LT Debt VS Equity VS FCFCAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

CAN has a Current Ratio of 2.69. This indicates that CAN is financially healthy and has no problem in meeting its short term obligations.
CAN's Current ratio of 2.69 is amongst the best of the industry. CAN outperforms 84.38% of its industry peers.
CAN has a Quick Ratio of 1.64. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.64, CAN is doing good in the industry, outperforming 71.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.64
CAN Yearly Current Assets VS Current LiabilitesCAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.98% over the past year.
EPS 1Y (TTM)72.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%80.89%

3.2 Future

Based on estimates for the next years, CAN will show a very strong growth in Earnings Per Share. The EPS will grow by 80.78% on average per year.
Based on estimates for the next years, CAN will show a very strong growth in Revenue. The Revenue will grow by 88.91% on average per year.
EPS Next Y157.71%
EPS Next 2Y80.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year163.26%
Revenue Next 2Y88.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CAN Yearly Revenue VS EstimatesCAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
CAN Yearly EPS VS EstimatesCAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 2.58 indicates a rather cheap valuation of CAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CAN indicates a rather cheap valuation: CAN is cheaper than 93.75% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CAN to the average of the S&P500 Index (20.86), we can say CAN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.58
CAN Price Earnings VS Forward Price EarningsCAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAN Per share dataCAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 0.8

4.3 Compensation for Growth

CAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CAN's earnings are expected to grow with 80.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.78%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANAAN INC

NASDAQ:CAN (5/2/2025, 10:33:33 PM)

After market: 0.6924 +0 (+0.71%)

0.6875

0 (-0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)03-26 2025-03-26/bmo
Earnings (Next)05-15 2025-05-15
Inst Owners31.25%
Inst Owner Change0.32%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap257.21M
Analysts82.22
Price Target4.13 (500.73%)
Short Float %74.68%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-126.4%
Min EPS beat(2)-186.61%
Max EPS beat(2)-66.2%
EPS beat(4)0
Avg EPS beat(4)-109.18%
Min EPS beat(4)-186.61%
Max EPS beat(4)-66.2%
EPS beat(8)2
Avg EPS beat(8)-47.5%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)25.43%
Min Revenue beat(2)8.9%
Max Revenue beat(2)41.96%
Revenue beat(4)2
Avg Revenue beat(4)4.46%
Min Revenue beat(4)-18.75%
Max Revenue beat(4)41.96%
Revenue beat(8)4
Avg Revenue beat(8)67.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.73%
PT rev (3m)13.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.58
P/S 1.22
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)0.27
Fwd EY38.78%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.57
BVpS0.93
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -83.97%
ROE -118.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.81%
ROA(5y)-32.65%
ROE(3y)-16.7%
ROE(5y)-49.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.55%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 1.64
Altman-Z -1.1
F-Score2
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)129.57%
Cap/Depr(5y)93.27%
Cap/Sales(3y)1.49%
Cap/Sales(5y)1.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
EPS Next Y157.71%
EPS Next 2Y80.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%80.89%
Revenue Next Year163.26%
Revenue Next 2Y88.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1642.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.67%
EBIT Next 3Y34.57%
EBIT Next 5YN/A
FCF growth 1Y52.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.98%
OCF growth 3YN/A
OCF growth 5YN/A